SenesTech Posts Record Q3 2025 Revenue, Pushes Toward Profitability

SenesTech, Inc. (NASDAQ: SNES) reported a strong third quarter for 2025, detailing key metrics that suggest the pest‑control innovator is gaining momentum. Revenue rose by 43% year‑over‑year, reaching $690,000, from about $482,000 in Q3 2024. The company’s flagship product line, Evolve® Rodent Birth Control™, drove the surge—sales jumped 77% YoY and now represent 85% of total revenue. Gross margin held steady at 62.8% (rounded) and the adjusted EBITDA loss improved to $1.2 million, the best in company history. Strategically, SenesTech highlighted growth across multiple distribution channels: e‑commerce rose ~55% YoY, municipal deployments soared ~139% YoY, and retail revenue jumped ~254% YoY. The company ended the quarter with a cash and short‑term investment balance of about $10.2 million, giving it a runway as it works toward profitability. While the net loss for the quarter was ~$1.3 million (versus ~$1.5 million a year prior), management emphasized that one‑time legal and lease costs slightly impacted the result; excluding those, the loss would have been around $1.1 million. CEO Joel Fruendt noted that the company’s multi‑channel strategy is taking hold and voiced confidence in “transformational growth” opportunities ahead. Looking forward, SenesTech appears focused on scaling its Evolve product, expanding into new markets (including globally), and further reducing losses while avoiding additional equity raises. The market reaction was cautiously optimistic—despite missing some analyst expectations, the core growth story remains intact. #SenesTech #RodentControl #EvolveProduct #Q32025Results #SlimScan #GrowthStocks #CANSLIM